Between our comprehensive services and decades of therapeutic experience, we have the expertise to handle every aspect of your product’s early development—no matter the type of drug or clinical trial. These are some of the many specialties we’ve cultivated over the years, to provide fast, innovative solutions for your drug’s development.
Leverage our scientific knowledge and therapeutic insight to help you through Proof of Concept and beyond.
With nearly 50 years of experience in biologic drug development, we provide fast, reliable assessments of your biosimilar’s viability. Individual consultation and all-inclusive services are both available, from preclinical to pivotal clinical studies.
Utilizing 15 years of experience in nicotine research, we evaluate the safety of your modified risk nicotine product and help you navigate the ever-changing regulatory landscape. We offer full-service expertise, which includes study design, execution, analysis, and reporting, to get your product to market faster.
With our deep understanding of the patient population and study designs employed, we can ensure your studies are completed on time with high-quality data.
Over the years, we’ve conducted 450+ cardiovascular safety studies, including thorough QT and intensive ECG studies. Our team’s leadership is built around decades of experience, and by offering comprehensive services (from planning to execution and analysis), we’re able to efficiently provide higher quality data for studies on cardiovascular safety.
Our scientists can create efficient, cost-effective packages of product labeling studies, applying their knowledge of the drug throughout their conduct and analysis.
Celerion 2026. All Rights Reserved. Privacy & Legal